Cubist Systematic Strategies, LLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 107 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 5.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$0
-100.0%
2
-100.0%
0.00%
Q2 2022$25,000
-13.8%
28,500
+23.4%
0.00%
Q1 2022$29,000
-29.3%
23,096
+56.1%
0.00%
-100.0%
Q3 2021$41,000
-87.1%
14,800
-85.3%
0.00%
-75.0%
Q2 2021$317,000
+51.7%
100,656
+2.4%
0.00%
+33.3%
Q1 2021$209,000
+450.0%
98,290
+399.2%
0.00%
+200.0%
Q4 2020$38,00019,6900.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
GARRISON BRADFORD & ASSOCIATES INC 20,000$14,0000.02%
Hartford Financial Management Inc. 16,000$11,0000.00%
RBF Capital, LLC 25,000$19,0000.00%
Koshinski Asset Management, Inc. 20,000$14,0000.00%
Financial Advocates Investment Management 23,097$16,0000.00%
D.A. DAVIDSON & CO. 110,000$76,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 162,714$112,0000.00%
HighTower Advisors, LLC 132,328$91,0000.00%
Virtu Financial LLC 15,854$11,0000.00%
BlackRock Inc. 31,631$22,0000.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders